Patriapharma
Patriapharma, officially known as C.F. Pharma Kft., is a prominent player in the pharmaceutical industry, headquartered in Hungary (HU). Established in 2006, the company has made significant strides in the development and distribution of high-quality pharmaceutical products, primarily focusing on generic medications and innovative therapies. With a strong operational presence across Europe, Patriapharma is recognised for its commitment to quality and compliance, ensuring that its offerings meet stringent regulatory standards. The company’s core products include a diverse range of generic drugs that cater to various therapeutic areas, setting them apart through rigorous research and development processes. Patriapharma has achieved notable market positioning, earning a reputation for reliability and excellence in the pharmaceutical sector. Its dedication to advancing healthcare solutions continues to drive its growth and influence within the industry.
DitchCarbon Score
How does Patriapharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Patriapharma's score of 3 is higher than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Patriapharma's reported carbon emissions
Patriapharma, headquartered in Hungary (HU), currently does not have available data on its carbon emissions, as no specific emissions figures have been provided. Consequently, there are no reported Scope 1, 2, or 3 emissions data to analyse. In the absence of concrete emissions statistics, it is important to note that the company has not outlined any specific reduction targets or initiatives related to climate commitments. This lack of information suggests that Patriapharma may still be in the early stages of developing a comprehensive climate strategy or may not have publicly disclosed its commitments. As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Patriapharma to establish clear climate goals and transparency in emissions reporting to align with global efforts to combat climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Patriapharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
